CDH13 and chronic myelogenous leukemia, BCR-ABL1 positive: T-cadherin has been suggested as a tumor suppressor, since in several types of cancer, including B-cell lymphoma and chronic myeloid leukemia (CML), it has been found to be down-regulated by allelic deletion and/or by promoter hypermethylation [28].